Next, we investigated whether long-term treatment with INT-767 can prevent metabolic disorders in Apoe−/− mice, which can develop all the features of diet-induced metabolic disorders, including obesity, NAFLD, and atherosclerosis. This evidence concerns the gene APOE and metabolic disease.